Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...

Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot causes excessive bone mineral density loss.

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Early studies show a drug can effectively 'switch on' particular cells within the nervous system that play an important role ...

There's new data suggesting that diabetes and weight-loss meds like Ozempic and Wegovy might help people curb problem ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

Dr. Todd Ellerin, Vice Chair of Medicine at South Shore Health, talks to WCVB's Ed Harding about the effects popular ...

Ozempic and Wegovy Popular drugs like Ozempic and Wegovy are known for dramatic weight loss, but they also can potentially ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...